Transplant Oncology Research Group

Pål Dag LineGroup leader
Pål Dag Line
Group leader

The research group for Transplant Oncology is exploring liver transplantation as a treatment option for patients with primary or secondary liver malignancies that currently are treated by palliative care due to lack of surgical possibilities. 

The group has been leading the field of liver transplant for colorectal liver metastases (CRLM), and transplant oncology has become an emerging field in liver transplantation with international traction. The reserch group for transplant oncology is currently running prospective study protocols in liver transplantation in colorectal liver metastasis, intrahepatic cholangiocarcinoma and hilar cholangiocarcinoma, and is also tightly involved in liver metastases from neuroendocrine tumors.

Members of the research group are transplant surgeons, oncologists, radiologists, nuclear medicine specialists, liver surgeons and thorax surgeons and nurses.  The research group also has an established cooperation with academic expertise in health economics.